Envista Holdings Corp

Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The firm operates through the following segments: Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segments develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems, handpieces and associated consumables, treatment units and other dental practice equipment, endodontic systems and related consumables, restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. It offers dental consumables, equipment, and services to dental professionals. The company was founded on August 29, 2018, and is headquartered in Brea, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Envista Holdings Corp posts robust 2022 results amidst market challenges

Envista Holdings Corp reported strong 2022 performance with core sales growth and expanded EBITDA margins. Despite Q4 challenges, the company remains optimistic about long-term growth prospects in the dental market. Envista's strategic focus on innovation, operational efficiency, and disciplined growth strategies underpin its commitment to achieving long-term targets and driving shareholder value.

Envista Holdings Corp reports Q1 challenges but sees growth opportunities

Envista Holdings Corp faces challenges in core sales and EBITDA margins in Q1 2023, with a focus on accelerating organic growth and improving the E&C business. Despite short-term uncertainties in China and Russia, the company sees opportunities in expanding margins and driving growth through strategic shifts.

Envista Holdings Corp reports solid Q2 performance amidst market challenges

Envista Holdings Corp (NVST) delivered a resilient performance in Q2 2023, showcasing strengths in core revenue growth, operational improvements, and cash flow generation. While facing challenges in certain segments and regions, the company remains optimistic about achieving its full-year guidance and capitalizing on growth opportunities through strategic initiatives.

Envista Holdings Corp reports positive Q3 performance amidst challenges

Envista Holdings Corp reported positive core growth and margin performance in Q3 2023.
Challenges in the implant business and distribution channels are being addressed through strategic investments.
The company is committed to balancing growth and margin expansion for long-term success.
Envista reaffirms its dedication to navigating challenges and driving future growth.

Envista Holdings Corp reports mixed 2023 performance, eyes growth opportunities

Envista Holdings Corp's 2023 performance showed mixed results with challenges in the global dental market and specific issues impacting segments like Equipment & Consumables. Despite these challenges, the company is focusing on optimizing operations, accelerating key businesses, and navigating short-term issues to drive long-term growth. Envista remains cautiously optimistic about 2024, expecting low single-digit core sales growth and improved margins.

Envista reports modest Q1 growth, eyes China for expansion

Envista Holdings Corp (NVST) reported modest Q1 growth, with a focus on accelerating orthodontic and implant businesses, driving operational improvements, and addressing market challenges.
The company is optimistic about its growth potential in China, aiming to close the gap in market growth in North America and reinvigorate growth in the region.
Envista's strategic investments, focus on cost optimization, and plans for talent acquisition position the company for long-term value creation and success in the industry.

Envista Holdings Corp reports Q2 challenges but sees growth opportunities

Envista Holdings Corp faced challenges with core sales decline and impairment charges but improved free cash flow significantly.
Despite the setbacks, the company made strategic investments and saw growth in active Spark doctors and international expansion.
Envista's focus on market conditions, new appointments, and expanding Spark presents opportunities for future growth and success.

Envista Holdings Corp reports mixed Q3 results, eyes margin improvement

Envista's Q3 performance reflects a mix of strengths and challenges, with opportunities for margin improvement and market expansion.
Strong free cash flow and growth in specific segments demonstrate operational resilience and strategic focus.
Management's optimism for future performance indicates confidence in the company's ability to navigate current market dynamics.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. It operates through Specialty Products and Technologies, and Equipment and Consumables segments. The Specialty Products and Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment and Consumables segments develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems, handpieces and associated consumables, treatment units and other dental practice equipment, endodontic systems and related consumables, restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. It offers dental consumables, equipment, and services to dental professionals. The company was founded on August 29, 2018, and is headquartered in Brea, CA.

BREA, Calif., Dec. 27, 2021 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the U.S. Food and Drug Administration (FDA) has cleared the Nobel Biocare N1™ implant system.

Nobel Biocare Receives FDA 510(k) Clearance for the Nobel Biocare N1™ Implant System

Envista Holdings has been repositioning the portfolio after the 2019 spin-off from Danaher. The company has seen a harsh 2020 amidst the pandemic, leverage and the fact that the business was spun-off just before the pandemic.

Envista Holdings: Not Making A Dent

BREA, Calif., Dec. 23, 2021 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced an update to the company's participation at the 40th Annual J.P.

Update to Envista participation at J.P. Morgan Healthcare Conference

BREA, Calif., Dec. 22, 2021 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced it has entered into a definitive agreement to acquire Carestream Dental's Intra-Oral Scanner (IOS) business for $600 million.

ENVISTA TO ACQUIRE CARESTREAM DENTAL INTRA-ORAL SCANNER BUSINESS

BREA, Calif., Dec. 7, 2021 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the following upcoming investor conferences: Stifel MedTech Madness 2021 Annual West Coast Bus Tour at the Montage Laguna Beach Hotel on Wednesday, December 15, 2021 from 7:00 – 8:00 AM PST.

Envista Announces Participation in Upcoming Investor Conferences

Envista Holdings Corporation (NVST) CEO Amir Aghdaei on Q3 2021 Results - Earnings Call Transcript

Envista (NVST) delivered earnings and revenue surprises of 12.50% and -10.25%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Envista (NVST) Q3 Earnings Beat Estimates

BREA, Calif., Nov. 3, 2021 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the third quarter 2021.

Envista Reports Third Quarter 2021 Results

BREA, Calif., Oct. 11, 2021 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its third quarter 2021 on Wednesday, November 3, 2021.

Envista Schedules Third Quarter 2021 Earnings Call

Envista has agreed to dispose of its KaVo treatment unit and instruments business to Planmeca for up to $455 million consideration.

Envista: A Leaner And Meaner Business Post KaVo Sale

Boise Cascade

Group 1 Automotive

Hibbett Sports

Honda

Vishay Intertechnology

P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects.

6 Low Price-to-Book Stocks to Increase Your Portfolio's Value

Boston Scientific

NVST vs. BSX: Which Stock Is the Better Value Option?

NVST or BSX: Which Is the Better Value Stock Right Now?

Celestica

Gap Inc

The P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.

7 Low Price-to-Book Stocks to Buy in September

NVST vs. BSX: Which Stock Should Value Investors Buy Now?

BREA, Calif., Sept. 7, 2021 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced it entered into a binding agreement to sell its KaVo Treatment Unit and Instrument business to planmeca Verwaltungs GmbH ("Planmeca") for up to $455 million, which includes a potential earn-out payment of up to $30 million.

Envista Announces Intended Sale Of KaVo Treatment Unit & Instrument Business To Planmeca

BREA, Calif., Sept. 1, 2021 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Baird Global Healthcare Virtual Conference on Tuesday, September 14, 2021 at 2:35 PM ET.

Envista Announces Participation In Baird Global Healthcare Conference

Conn's

Lincoln National

ON Semiconductor

P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.

7 Value Stocks to Unlock Gains Using Price-to-Book Ratio

Affiliated Managers

Bassett Furniture

Vale S.A.

7 Low Price-to-Book Value Picks for August

Envista Holdings Corporation (NVST) CEO Amir Aghdaei on Q2 2021 Results - Earnings Call Transcript

Envista (NVST) delivered earnings and revenue surprises of 20.46% and 4.87%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Envista (NVST) Q2 Earnings and Revenues Top Estimates

Shares of Envista Holdings (NYSE:NVST) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 630.00% year over year to $0.53, which beat the estimate of $0.45.

Recap: Envista Holdings Q2 Earnings

BREA, Calif., Aug. 3, 2021 /PRNewswire/ -- Envista Holdings (NYSE: NVST) today announced results for the second quarter 2021.

Envista Reports Second Quarter 2021 Results

Envista (NVST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

News for Envista Holdings Corp Stock (NVST)